INDV
#1365
Indivior Pharmaceuticals, Inc. - Common Stock
41.1 7 USD
+0.02%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+2.34%
Variación mensual
+6.60%
Variación en los últimos 6 meses
+22.53%
Cambio anual
+22.53%
Cierres anteriores
40.2 3
Open
41.2 9
Mínimo
40.9 7
High
41.3 1
Volumen
562
Financials
- Market Capitalization 5.02 B
- Employee 838
- Founded 2014
- CEO Mark Crossley
- Website www.indivior.com
- Headquarter Delaware, United States
- FIGI BBG01ZTXFLQ6
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
15.63
Relación precio/flujo de caja
3.02
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1143 |  LNTH Lantheus Holdings, Inc. - Common Stock | 104.83 USD | +2.40% | -1.54% | -0.16% | +87.00% | 6.83 B USD | ||
| 1288 |  AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock | 17.21 USD | +3.12% | +2.75% | +5.58% | +63.13% | 5.49 B USD | ||
| 1803 |  SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 47.43 USD | +1.65% | -2.45% | +7.58% | -12.17% | 2.75 B USD | ||
| 1836 |  RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.21 USD | -7.79% | -18.85% | -69.30% | -64.07% | 2.58 B USD |